The Almaty City Cardiology Center has expanded its capacity to provide high-tech care for patients with heart rhythm disorders, QazMonitor reports.
With partner support, the center received a second cryoballoon console for temporary use to perform cryoablation in patients with atrial fibrillation, according to the city’s Public Health Department.
Arthur Abdymomunov, head of the Arrhythmology Department, said atrial fibrillation remains the most common heart rhythm disorder in Almaty and across Kazakhstan. The condition significantly increases the risk of stroke and heart failure and reduces patients’ quality of life.
Atrial fibrillation is characterized by chaotic electrical activity in the atria, leading to irregular and often rapid heartbeats. Cryoballoon ablation is a minimally invasive procedure in which sources of abnormal electrical impulses are isolated through controlled low-temperature exposure.
According to the center, about 170 cryoballoon ablation procedures were performed in 2025. Following the commissioning of the second console in 2026, the number of procedures is expected to nearly double, expanding patient access and reducing waiting times.
The center noted that increased technical capacity is particularly important for a major city where the number of patients with heart rhythm disorders continues to grow. All procedures are covered by the Mandatory Social Health Insurance system and are free of charge for citizens of Kazakhstan.
